Tolerance to desvenlafaxine in rapid metabolizing depressed patients

International Clinical Psychopharmacology

Volumn 26, Issue 2, 2011, Pages 84-87

  Parker, Gordon B ^a,b   Brotchie, Heather L ^a,b   Hyett, Matthew ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

desvenlafaxine succinate; drug tolerance; metabolism; tachyphylaxis

Indexed keywords

CITALOPRAM; CYTOCHROME P450 2C19; DESVENLAFAXINE; DOSULEPIN; DRUG METABOLITE; LITHIUM; METHYLPHENIDATE; MIANSERIN; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORDOSULEPIN; OLANZAPINE; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DETERIORATION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG METABOLISM; DRUG TOLERANCE; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; GENOTYPE; HUMAN; MAJOR DEPRESSION; MALE; MELANCHOLIA; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; DEPRESSIVE DISORDER, MAJOR; DRUG TOLERANCE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 79951508520     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328341e333     Document Type: Article

References (7)

1. Byrne SE, Rothschild AJ (1998). Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. J Clin Psychiatry 59:279-288. (Pubitemid 28353975)
2. Parker G, Rowe M, Mehta F, Kumar S (2010). An evaluation of a new genotyping test for predicting response to antidepressant drugs. Australas Psychiatry 18:413-416.
3. Preskorn S, Patroneva A, Silman H, Jiang Q, Isler JA, Burczynski ME, et al. (2009). Comparison of the pharmokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabo-lizers. J Clin Psychopharmacol 29:39-43.
4. Quitkin FM, Rabkin JG, Ross D, Stewart JW (1984). Identification of true drug response to antidepressants: use of pattern analysis. Arch Gen Psychiatry 41:132-139.
5. Sistonen J, Fuselli S, Levo A, Sajantila A (2005). CYP2D6 genotyping by a multiplex primer extension. Clin Chem 51:1291-1295. (Pubitemid 43079419)
6. Solomon DA, Leon AC, Mueller TI, Coryell W, Teres JJ, Posternak MA, et al. (2005). Tachyphylaxis in unipolar major depressive disorder. J Clin Psychiatry 66:283-290. (Pubitemid 40476749)
7. Wyeth (2009). Pristiq Product Information. TGA Approval 16/12/2009. Wyeth Australia Pty Ltd, Baulkham Hills, Australia. pp. 1-15.